Polyrizon Ltd. PLRZ

$1.55 -0.09 (-5.49%)

Valuation

Market cap
—
Revenue TTM
—
Net income TTM
—
PE ratio
—
Forward PE
—
Profit margin
—
Debt to equity
—

Trading

Volume
1,429,814
Avg volume
—
Day's range
$1.11 – $1.97
Shares out
—
Stochastic %K
—
Beta
—
Analysts
—
Price target
—

Price

Company profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker;...

Show more

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients. It also develops PL-14, a nasal allergies blocker; and PL-16 for influenza blockers. Polyrizon Ltd. was incorporated in 2005 is headquartered in Ra'anana, Israel.

Industry
Biotechnology
Sector
Healthcare
Phone
972 9 374 0120
Website
https://www.polyrizon-biotech.com
Address
5 HaPnina Street, Ra'anana, Israel

Latest news

Stocktwits

RAClose Oct 10, 1:57 AM
$PLRZ I've been waiting since June to get back into this, I'll give it a few days to marinate before deciding if to pull the trigger.
0 replies
Tbirdyguy Oct 9, 7:43 PM
$PLRZ trash company and rash
0 replies
patrick1956 Oct 7, 11:08 PM
$PLRZ ...this is an Isreal company....most of their stuff is control by Zionist propaganda...i could be wrong...all these different testing makes me feel...its just a scam....imo
1 replies
Tbirdyguy Oct 6, 1:15 PM
$PLRZ cooked...
1 replies
flychicken1991 Oct 5, 11:38 AM
$PLRZ Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform. Impact: Positive (82%). could receive modest upward valuation support from potential additional protection for its intranasal platform, although the filing alone provides no demonstrated improvement in earnings or cash flow. Source and what to watch next: https://nimpact.tech/newsimpact/news/e1c78441b6eafc6d/plrz-polyrizon-files-for-u-s-patent-application-to-expand-ip-moat-around?utm_source=stocktwits&utm_medium=story_url
0 replies
Tbirdyguy Oct 2, 6:52 PM
$PLRZ ouch
1 replies
focafoca99 Sep 28, 8:48 PM
$PLRZ shared its six-month 2026 interim results for the period ended June 30.
0 replies
Tbirdyguy Sep 25, 5:08 PM
$PLRZ wtf this stock sucks balls
0 replies